{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:02Z","timestamp":1787883422257,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02167-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:13:14Z","timestamp":1781712794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple Clustering Algorithms for Ovarian Cancer Subtyping (MCAOCS): identifying clinical phenotypes and treatment response in critical care"],"prefix":"10.1186","volume":"19","author":[{"given":"Yamin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"2167_CR1","first-page":"229","volume":"74","author":"F BRAY","year":"2024","unstructured":"Bray F, Laversanne M. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2167_CR2","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.3802\/jgo.2020.31.e70","volume":"31","author":"KEHOE S","year":"2020","unstructured":"Kehoe S. Figo staging in ovarian carcinoma and histological subtypes [J]. J Gynecol Oncol. 2020;31(4):e70.","journal-title":"J Gynecol Oncol"},{"issue":"22","key":"2167_CR3","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/cancers17223636","volume":"17","author":"VECERZANL CODRU I R","year":"2025","unstructured":"Codru I R Vecerzanl. When and for Whom Does Intensive Care Unit Admission Change the Prognosis in Oncology?-A Scoping Review [J]. Cancers (Basel). 2025;17(22):3636.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2167_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijciis.ijciis_20_22","volume":"13","author":"J RITCHIE","year":"2023","unstructured":"Ritchie J, Birsner M L, Zighelboim I, et al. Common obstetrics and gynecologic topics in critical care: A narrative review [J]. Int J Crit Illn Inj Sci. 2023;13(1):38\u201343.","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"1","key":"2167_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41598-024-51699-z","volume":"14","author":"J DE KOK J, VAN ROSMALEN F, KOEZE","year":"2024","unstructured":"De Kok J, Van Rosmalen F, Koeze J, et al. Deep embedded clustering generalisability and adaptation for integrating mixed datatypes: two critical care cohorts [J]. Sci Rep. 2024;14(1):1045.","journal-title":"Sci Rep"},{"issue":"20","key":"2167_CR6","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"S SEYMOUR C W, KENNEDY J N, WANG","year":"2019","unstructured":"Seymour C W, Kennedy J N, Wang S, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis [J]. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"1","key":"2167_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12859-021-04279-1","volume":"22","author":"G BRI\u00e8RE","year":"2021","unstructured":"Bri\u00e8re G, Darbo \u00c9, Th\u00e9bault P, et al. Consensus clustering applied to multi-omics disease subtyping [J]. BMC Bioinformatics. 2021;22(1):361.","journal-title":"BMC Bioinformatics"},{"issue":"Pt A","key":"2167_CR8","doi-asserted-by":"publisher","first-page":"106270","DOI":"10.1016\/j.compbiomed.2022.106270","volume":"151","author":"B LI","year":"2022","unstructured":"Li B, Yu L. Cancer classification based on multiple dimensions: SNV patterns [J]. Comput Biol Med. 2022;151(Pt A):106270.","journal-title":"Comput Biol Med"},{"key":"2167_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jare.2024.04.007","volume":"69","author":"S LIU","year":"2025","unstructured":"Liu S, Meng Y, Zhang Y, et al. Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinoma [J]. J Adv Res. 2025;69:107\u201323.","journal-title":"J Adv Res"},{"key":"2167_CR10","doi-asserted-by":"crossref","unstructured":"Dyikanov D, Zaitsev A, Vasileva T et al. Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer [J]. Cancer Cell, 2024, 42(5): 759\u2009\u2013\u200979.e12.","DOI":"10.1016\/j.ccell.2024.04.008"},{"issue":"1","key":"2167_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"BULGARELLIL JOHNSON A E W","year":"2023","unstructured":"Johnson A E W Bulgarellil, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset [J]. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"key":"2167_CR12","doi-asserted-by":"publisher","first-page":"180178","DOI":"10.1038\/sdata.2018.178","volume":"5","author":"JD POLLARD T J, JOHNSON A E W, RAFFA","year":"2018","unstructured":"Pollard T J, Johnson A E W, Raffa JD, et al. The eICU Collaborative Research Database, a freely available multi-center database for critical care research [J]. Sci Data. 2018;5:180178.","journal-title":"Sci Data"},{"issue":"3","key":"2167_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC AUSTIN","year":"2011","unstructured":"Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies [J]. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"1","key":"2167_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y BENJAMINI","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing [J]. J Royal Stat Soc Ser B: Methodological. 1995;57(1):289\u2013300.","journal-title":"J Royal Stat Soc Ser B: Methodological"},{"issue":"4","key":"2167_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/2211-5463.13553","volume":"13","author":"YA WANG","year":"2023","unstructured":"Wang YA, Neff R, Song W M, et al. Multi-omics-based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis [J]. FEBS Open Bio. 2023;13(4):617\u201337.","journal-title":"FEBS Open Bio"},{"issue":"8","key":"2167_CR16","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1002\/ctm2.500","volume":"11","author":"Q HAO","year":"2021","unstructured":"Hao Q, Li J, Zhang Q, et al. Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma [J]. Clin Transl Med. 2021;11(8):e500.","journal-title":"Clin Transl Med"},{"issue":"6","key":"2167_CR17","first-page":"1921","volume":"25","author":"WIGUNA I G W W","year":"2025","unstructured":"Wiguna I G W W, Sadeva I G K A, Remitha N P S I, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers in Ovarian Cancer Among the Asian Population: A Systematic Review and Meta-Analysis [J]. Oman Med J. 2025;25(6):1921\u201343.","journal-title":"Oman Med J"},{"key":"2167_CR18","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.2147\/OTT.S264118","volume":"13","author":"J YANG","year":"2020","unstructured":"Yang J, Ma J, Cheng S, et al. The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer [J]. Onco Targets Ther. 2020;13:7283\u201393.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2167_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-023-01116-2","volume":"16","author":"CL ZHANG","year":"2023","unstructured":"Zhang CL, Jiang X C, Li Y, et al. Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR [J]. J Ovarian Res. 2023;16(1):36.","journal-title":"J Ovarian Res"},{"key":"2167_CR20","doi-asserted-by":"publisher","first-page":"1546474","DOI":"10.3389\/fimmu.2025.1546474","volume":"16","author":"X ZHANG","year":"2025","unstructured":"Zhang X, Zhang W, Zhang H, et al. Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies [J]. Front Immunol. 2025;16:1546474.","journal-title":"Front Immunol"},{"issue":"1","key":"2167_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13054-020-2778-x","volume":"24","author":"JG WILSON","year":"2020","unstructured":"Wilson JG, Calfee CS. ARDS Subphenotypes: Understanding a Heterogeneous Syndrome [J]. Crit Care. 2020;24(1):102.","journal-title":"Crit Care"},{"issue":"1","key":"2167_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/atm-20-4634","volume":"9","author":"S GAO","year":"2021","unstructured":"Gao S, Wang Y, Yang L, et al. Characteristics and clinical subtypes of cancer patients in the intensive care unit: a retrospective observational study for two large databases [J]. Ann Transl Med. 2021;9(1):13.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2167_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41467-024-55330-7","volume":"16","author":"L KLEIN","year":"2025","unstructured":"Klein L, Tu M, Krebs N, et al. Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer [J]. Nat Commun. 2025;16(1):335.","journal-title":"Nat Commun"},{"key":"2167_CR24","doi-asserted-by":"publisher","first-page":"929572","DOI":"10.3389\/fendo.2022.929572","volume":"13","author":"M AGUILAR-CAZARES D, CHAVEZ-DOMINGUEZ","year":"2022","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Marroquin-Muci\u00f1o M, et al. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment [J]. Front Endocrinol (Lausanne). 2022;13:929572.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2167_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V ARROYO","year":"2021","unstructured":"Arroyo V, Angeli P, Moreau R, et al. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis [J]. J Hepatol. 2021;74(3):670\u201385.","journal-title":"J Hepatol"},{"key":"2167_CR26","doi-asserted-by":"publisher","first-page":"1520848","DOI":"10.3389\/fimmu.2025.1520848","volume":"16","author":"HALSTEAD E S","year":"2025","unstructured":"Halstead E S, Mckeone D J, Samuelsen A M, et al. Functional immune profiling of hyper- and hypo-inflammatory subphenotypes of critical illness: a secondary analysis [J]. Front Immunol. 2025;16:1520848.","journal-title":"Front Immunol"},{"key":"2167_CR27","doi-asserted-by":"publisher","first-page":"1252021","DOI":"10.3389\/fmed.2023.1252021","volume":"10","author":"A CLEUREN","year":"2023","unstructured":"Cleuren A, Molema G. Organotypic heterogeneity in microvascular endothelial cell responses in sepsis-a molecular treasure trove and pharmacological Gordian knot [J]. Front Med (Lausanne). 2023;10:1252021.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"2167_CR28","first-page":"94","volume":"55","author":"LIU M W","year":"2025","unstructured":"Liu M W, Duan S X, Zhao X Y, et al. Research status and advances in dexmedetomidine for sepsis\u2013induced multiple organ dysfunction syndrome (Review) [J]. Int J Mol Med. 2025;55(6):94.","journal-title":"Int J Mol Med"},{"issue":"4","key":"2167_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/s-0039-1687894","volume":"45","author":"Y HISADA","year":"2019","unstructured":"Hisada Y, Mackman N. Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis [J]. Semin Thromb Hemost. 2019;45(4):385\u201395.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2167_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","volume":"162","author":"A GADDUCCI","year":"2021","unstructured":"Gadducci A, Multinu F, Cosio S, et al. Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes [J]. Gynecol Oncol. 2021;162(3):741\u201350.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2167_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ijgc-2020-001656","volume":"31","author":"Y IIDA","year":"2021","unstructured":"Iida Y, Okamoto A, Hollis RL, et al. Clear cell carcinoma of the ovary: a clinical and molecular perspective [J]. Int J Gynecol Cancer. 2021;31(4):605\u201316.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"2167_CR32","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.62347\/EDAR9565","volume":"16","author":"H LIAN","year":"2024","unstructured":"Lian H, Cai H, Zhang H, et al. Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients [J]. Am J Transl Res. 2024;16(10):5797\u2013812.","journal-title":"Am J Transl Res"},{"issue":"21","key":"2167_CR33","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-21-3819","volume":"82","author":"Y WANG","year":"2022","unstructured":"Wang Y, Xie H, Chang X, et al. Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer [J]. Cancer Res. 2022;82(21):3903\u201316.","journal-title":"Cancer Res"},{"key":"2167_CR34","doi-asserted-by":"publisher","first-page":"1372413","DOI":"10.3389\/fendo.2024.1372413","volume":"15","author":"L ZHU","year":"2024","unstructured":"Zhu L, Lin Z, Wang K, et al. A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer [J]. Front Endocrinol (Lausanne). 2024;15:1372413.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"19","key":"2167_CR35","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.3390\/cancers14194696","volume":"14","author":"MCLEANK TONDO-STEELE K","year":"2022","unstructured":"Tondo-Steele K Mcleank. The Sweet Spot of Targeting Tumor Metabolism in Ovarian Cancers [J]. Cancers (Basel). 2022;14(19):4696.","journal-title":"Cancers (Basel)"},{"key":"2167_CR36","doi-asserted-by":"publisher","first-page":"1661558","DOI":"10.3389\/fmolb.2025.1661558","volume":"12","author":"F JIANG","year":"2025","unstructured":"Jiang F, Fei H. Integrated analysis and experimental validation of E2F2 as a potential prognostic biomarker and its oncogenic roles in serous ovarian cancer [J]. Front Mol Biosci. 2025;12:1661558.","journal-title":"Front Mol Biosci"},{"issue":"9","key":"2167_CR37","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/cancers14092220","volume":"14","author":"D SCHWEER","year":"2022","unstructured":"Schweer D, Mcatee A, Neupane K, et al. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy [J]. Cancers (Basel). 2022;14(9):2220.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"2167_CR38","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1111\/jcmm.16907","volume":"25","author":"X LIU","year":"2021","unstructured":"Liu X, Wu A, Wang X, et al. Identification of metabolism-associated molecular subtype in ovarian cancer [J]. J Cell Mol Med. 2021;25(20):9617\u201326.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2167_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamaoncol.2023.4504","volume":"10","author":"M VENTIN","year":"2024","unstructured":"Ventin M, Cattaneo G, Maggs L, et al. Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy: A Review [J]. JAMA Oncol. 2024;10(1):115\u201321.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2167_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1021\/acssensors.4c02569","volume":"10","author":"G GOUVEIA","year":"2025","unstructured":"Gouveia G, Saateh A, Swietlikowska A, et al. Continuous Biosensing to Monitor Acute Systemic Inflammation, a Diagnostic Need for Therapeutic Guidance [J]. ACS Sens. 2025;10(1):4\u201314.","journal-title":"ACS Sens"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02167-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:26:56Z","timestamp":1787880416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02167-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study adhered to the principles of the Declaration of Helsinki and constituted a secondary analysis of de-identified patient data from two publicly available critical care databases: the Medical Information Mart for Intensive Care IV (MIMIC-IV) and the eICU Collaborative Research Database (eICU). The establishment and public release of the MIMIC-IV database received approval from the Institutional Review Boards of the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center. The eICU database was developed with approval from the Institutional Review Boards of all participating healthcare institutions. As this research exclusively involved the analysis of retrospective, fully de-identified data from these pre-approved, public resources, the requirement for obtaining additional ethical approval from our institution was waived. Prior to data access, all investigators completed the mandatory ethical training and strictly adhered to the data use agreements stipulated by both databases, ensuring compliant and responsible handling of the data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"271"}}